Letter to the editor

Results: 804



#Item
781Letter to the Editor Diagnostic Hematology Ann Lab Med 2014;34:[removed]

Letter to the Editor Diagnostic Hematology Ann Lab Med 2014;34:[removed]

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
782Letter to the Editor  A 53-year-old woman with thrombocytosis

Letter to the Editor A 53-year-old woman with thrombocytosis

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
783Letter to the Editor  Complex-I defect with minimal manifestations

Letter to the Editor Complex-I defect with minimal manifestations

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
784Letter to the Editor  Haemorrhoidal disease in severe portal hypertension:

Letter to the Editor Haemorrhoidal disease in severe portal hypertension:

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
785Letter to the Editor  Respiratory insufficiency with pneumonia following

Letter to the Editor Respiratory insufficiency with pneumonia following

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
786Letter to the Editor  Off-pump bilateral internal thoracic artery grafting

Letter to the Editor Off-pump bilateral internal thoracic artery grafting

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
787Letter to the Editor For reprint orders, please contact [removed]

Letter to the Editor For reprint orders, please contact [removed]

Add to Reading List

Source URL: coldcure.com

Language: English
788Letter to the Editor Slow Rates of Molecular Evolution Temperature Hypotheses

Letter to the Editor Slow Rates of Molecular Evolution Temperature Hypotheses

Add to Reading List

Source URL: vertebrates.si.edu

Language: English - Date: 2007-08-09 14:17:44
789A second letter was sent to Lancet on 6 April 2012, a letter which Lancet chose not to publish. We note that the Chief Editor of Lancet is a co-Board member of a drug law reform organisation of which two of the authors of the erroneous Lancet study which we have here addressed are also members

A second letter was sent to Lancet on 6 April 2012, a letter which Lancet chose not to publish. We note that the Chief Editor of Lancet is a co-Board member of a drug law reform organisation of which two of the authors of the erroneous Lancet study which we have here addressed are also members

Add to Reading List

Source URL: www.drugfree.org.au

Language: English - Date: 2013-08-01 07:44:10
790Letter to the Editor Add Sucralfate to List of

Letter to the Editor Add Sucralfate to List of

Add to Reading List

Source URL: www.cutis.com

Language: English - Date: 2007-11-10 16:09:00